Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment
- 1 December 1997
- journal article
- research article
- Published by Wiley in The Anatomical Record
- Vol. 249 (4) , 458-468
- https://doi.org/10.1002/(sici)1097-0185(199712)249:4<458::aid-ar5>3.0.co;2-n
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic ratsBone, 1995
- Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compoundJournal of Bone and Mineral Research, 1994
- Greater bone formation induction occurred in aged than young cancellous bone sitesBone, 1993
- Quantitative analysis of trabecular bone structureBone, 1993
- BM 21.0955, a potent new bisphosphonate to inhibit bone resorptionJournal of Bone and Mineral Research, 1991
- The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in ratsJournal of Bone and Mineral Research, 1991
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.Journal of Clinical Investigation, 1983
- The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing ratThe Anatomical Record, 1979
- Rate of normal longitudinal bone growth in the ratCalcified Tissue International, 1972